MoS Health addresses TB Health Technologies workshop
Urges Innovators to produce quality products that can be deployed at scale
Urges Innovators to produce quality products that can be deployed at scale
New facility will strengthen the security of supply for global pharmaceutical and biotech customers and will support the continued development and production of lifesaving clinical and commercial-scale therapeutics for patients worldwide.
With over 150 leading companies, 300+ topline brands and knowledge-led conference sessions, the event is set to make a grand return to the South
Pharmaceutical sales was flat and stood at Rs. 309 crore as compared to Rs. 308 crore in Q4 FY22
The New State-of-Art OligoPilot 2000 solid-phase synthesizer adds cGMP manufacturing capacity to support and accelerate clinical and commercial oligonucleotide programs.
Open, scalable, end-to-end solution to improve diagnostic quality and efficiency
Time to combine innovation, access and technology to deliver positive patient outcomes
Smart-performance, fully biodegradable biopolymer sourced from renewable raw materials
Nearly 5000 executives and more than 350 exhibitors turned out at the largest post-pandemic pharma packaging event
Subscribe To Our Newsletter & Stay Updated